Global Disruptive Behavior Disorder Treatment Market Insights, Size, and Forecast By Age Group (Children, Adolescents, Adults), By Treatment Type (Medication, Therapy, Behavioral Interventions, Counseling), By End User (Hospitals, Specialized Clinics, Homecare Settings, Research Institutions), By Disorder Type (Oppositional Defiant Disorder, Conduct Disorder, Intermittent Explosive Disorder), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035
Key Market Insights
Global Disruptive Behavior Disorder Treatment Market is projected to grow from USD 8.7 Billion in 2025 to USD 15.2 Billion by 2035, reflecting a compound annual growth rate of 6.4% from 2026 through 2035. This market encompasses the diagnostic tools, pharmacological interventions, and psychotherapeutic approaches employed to manage and alleviate symptoms associated with Disruptive Behavior Disorders DBDs, including Conduct Disorder, Oppositional Defiant Disorder, and Intermittent Explosive Disorder. Key market drivers include the rising global prevalence of these disorders, increasing awareness among parents and healthcare professionals, and the growing demand for effective treatment options. Additionally, advancements in understanding the neurobiological underpinnings of DBDs and the development of more targeted therapies are fueling market expansion. However, market growth is tempered by factors such as the social stigma associated with mental health conditions, the high cost of long term treatment, and the challenges in accurate diagnosis, particularly in early stages. Furthermore, the lack of standardized diagnostic criteria across regions can impede consistent market development.
Global Disruptive Behavior Disorder Treatment Market Value (USD Billion) Analysis, 2025-2035
2025 - 2035
www.makdatainsights.com
Important trends shaping the market include the shift towards personalized medicine, where treatment plans are tailored to individual patient profiles, and the increasing integration of digital health solutions, such as telemedicine and mobile applications, for remote monitoring and therapy delivery. There is also a notable trend towards combination therapies, leveraging both pharmacological and behavioral interventions for more comprehensive outcomes. Opportunities in this market lie in the development of novel non stimulant medications, the expansion of early intervention programs, and increased research into the genetic and environmental factors contributing to DBDs. The Children segment is currently the leading age group in the market, highlighting the critical need for effective interventions during formative years to prevent long term behavioral issues. This dominance underscores the focus on early diagnosis and treatment strategies aimed at improving developmental trajectories.
North America holds the dominant position in the global Disruptive Behavior Disorder Treatment Market. This leadership is attributable to well established healthcare infrastructure, high awareness levels regarding mental health disorders, significant research and development investments, and favorable reimbursement policies. The presence of numerous key market players and a high adoption rate of advanced diagnostic and treatment modalities also contribute to the region's strong market share. Conversely, Asia Pacific is projected to be the fastest growing region in the market. This rapid growth is driven by increasing healthcare expenditure, a rising awareness of mental health issues, improving access to healthcare services, and a large untapped patient population. Countries within Asia Pacific are witnessing a gradual shift in societal attitudes towards mental health, leading to greater acceptance of treatment. Key players such as Eli Lilly and Company, GlaxoSmithKline, AbbVie, Sumitomo Dainippon Pharma, Otsuka Pharmaceutical, Takeda Pharmaceutical Company, Bristol Myers Squibb, Johnson and Johnson, Ritter Pharmaceuticals, and AstraZeneca are focusing on strategies like R&D for new drug development, strategic collaborations, and expanding their geographical footprint to capitalize on emerging opportunities and consolidate their market presence. These companies are also investing in educational initiatives to improve diagnosis and reduce stigma associated with DBDs.
Quick Stats
Market Size (2025):
USD 8.7 BillionProjected Market Size (2035):
USD 15.2 BillionLeading Segment:
Children (51.8% Share)Dominant Region (2025):
North America (38.7% Share)CAGR (2026-2035):
6.4%
Global Disruptive Behavior Disorder Treatment Market Emerging Trends and Insights
AI Powered Personalized Therapies
AI powered personalized therapies are revolutionizing disruptive behavior disorder treatment by moving beyond generic approaches. Instead of one size fits all interventions, AI analyzes vast patient data including genetics, behavioral patterns, and treatment responses. This enables precise identification of unique patient characteristics and predictors of therapeutic success. Sophisticated algorithms then craft highly individualized treatment plans, optimizing medication regimens, behavioral interventions, and neurofeedback protocols. AI continuously monitors patient progress, adapting therapies in real time for maximum efficacy and minimal side effects. This tailored approach enhances treatment adherence, improves long term outcomes, and reduces the trial and error often associated with managing complex behavioral disorders, leading to more effective and efficient patient care.
Digital Therapeutics Expansion Beyond CBT
Digital therapeutics are increasingly broadening their scope beyond traditional cognitive behavioral therapy for disruptive behavior disorders. Initially lauded for their accessible and scalable delivery of CBT interventions, the market is now witnessing a significant evolution. New digital platforms are emerging that integrate a wider array of therapeutic modalities. This includes mindfulness based interventions, dialectical behavior therapy informed techniques, and even personalized neurofeedback protocols. These sophisticated programs leverage AI and machine learning to adapt content and strategies in real time, offering more nuanced and comprehensive support. Furthermore, there's a growing focus on integrating digital therapeutics with medication management and other clinical services, providing a holistic and multimodal treatment approach. This expansion reflects a recognition that effective disruptive behavior disorder treatment requires diverse, adaptable, and integrated digital solutions beyond the confines of basic CBT delivery.
Neurofeedback and Biomarker Driven Interventions
Neurofeedback and biomarker driven interventions are emerging as powerful tools in global Disruptive Behavior Disorder treatment. This trend signifies a shift from purely symptomatic management to personalized, data informed approaches. Neurofeedback directly trains brain activity, optimizing self regulation and executive function crucial for reducing impulsivity and aggression. Concurrently, identifying specific biomarkers through genetic testing or advanced imaging offers unprecedented insights into the underlying neurological mechanisms of disorders like ADHD and ODD. This allows clinicians to tailor interventions precisely. For example, a child with a particular genetic predisposition might receive neurofeedback targeting specific brain regions implicated by that biomarker. This integration of real time brain training with objective biological data promises more effective, targeted, and sustainable treatment outcomes, moving beyond broad spectrum psychopharmacology towards highly individualized therapeutic pathways.
What are the Key Drivers Shaping the Global Disruptive Behavior Disorder Treatment Market
Rising Global Prevalence and Awareness of DBD
The increasing recognition of Disruptive Behavior Disorder worldwide is a key market driver. As understanding of DBD grows among healthcare professionals, educators, and the general public, more individuals are being identified and seeking diagnosis. This heightened awareness is driven by improved diagnostic tools, increased research into the disorder’s impact, and a greater emphasis on child and adolescent mental health. Campaigns by mental health organizations and educational initiatives are further contributing to the destigmatization of mental health conditions, encouraging families to pursue treatment for children exhibiting DBD symptoms. This global shift in perception and knowledge translates directly into a higher demand for effective treatment options and support services.
Advancements in Diagnostic Tools and Therapeutic Interventions
Progress in diagnostic tools and therapeutic interventions significantly propels the global disruptive behavior disorder treatment market. Newer diagnostic tools offer enhanced accuracy and earlier detection of conditions like ADHD, ODD, and CD. This precision allows for more targeted and timely interventions, improving patient outcomes. Simultaneously, advancements in therapeutic approaches, including novel pharmacotherapies and sophisticated behavioral therapies, provide more effective and personalized treatment options. These innovations offer improved symptom management, reduced severity, and better long term prognoses for individuals with disruptive behavior disorders. This continuous development in both diagnosis and treatment efficacy directly contributes to increased demand and utilization of available therapies, driving market growth.
Increasing Healthcare Expenditure and Policy Support for Mental Health
Globally, a significant driver for the disruptive behavior disorder treatment market is the rising investment in healthcare, particularly concerning mental health. Governments and private entities are increasingly recognizing the substantial societal and economic burden of untreated mental health conditions, including disruptive disorders. This awareness translates into supportive policies aimed at improving access to diagnosis, therapy, and pharmacological interventions. Greater insurance coverage for mental health services, the integration of mental health into primary care, and public health campaigns are enhancing early identification and treatment initiation. This sustained increase in healthcare expenditure, coupled with policy frameworks prioritizing mental wellbeing, directly stimulates demand for innovative and effective disruptive behavior disorder treatments, fostering market expansion.
Global Disruptive Behavior Disorder Treatment Market Restraints
Ethical Implications of Predictive Analytics in DBD Treatment
Predictive analytics in Disruptive Behavior Disorder DBD treatment presents significant ethical hurdles. The core concern revolves around potential for misdiagnosis and stigmatization. Algorithms, however sophisticated, might inadvertently perpetuate biases present in historical data, leading to disproportionate labeling of certain demographic groups. There is also a risk of overreliance on technology, potentially diminishing the role of human clinical judgment and empathy. Patients could be inaccurately identified as high risk, leading to unnecessary interventions or discriminatory practices in education, employment, or social settings. Privacy of sensitive mental health data is another paramount ethical consideration, demanding robust security measures and transparent data governance to prevent misuse or breaches. Safeguarding individual autonomy and avoiding algorithmic determinism are crucial to ensure these technologies serve to enhance care ethically.
Regulatory Hurdles for Novel Neuro-Interventions in Global DBD Market
Regulatory hurdles significantly impede the widespread adoption and commercialization of groundbreaking neuro interventions for Disruptive Behavior Disorder. These obstacles manifest as complex, lengthy, and costly approval processes required by various national and international health authorities. Developers face rigorous preclinical and clinical trial demands, necessitating extensive data on safety, efficacy, and long term outcomes. Harmonization across different regulatory bodies remains a challenge, forcing companies to navigate disparate requirements in each target market. This fragmented landscape delays market entry, stifles innovation, and increases development costs, making it difficult for novel therapies to reach patients in need globally. The high bar for demonstrating clinical utility and managing potential risks restricts the pace at which disruptive treatments can penetrate the global market.
Global Disruptive Behavior Disorder Treatment Market Opportunities
Digital Therapeutics & AI-Driven Personalization for Disruptive Behavior Disorder Treatment
The global disruptive behavior disorder treatment market presents a significant opportunity for digital therapeutics and AI driven personalization. These innovative approaches offer scalable, accessible, and highly individualized interventions for conditions like ADHD and ODD. Digital platforms can deliver evidence based behavioral therapies directly to patients, overcoming geographical barriers and reducing the stigma associated with traditional clinical settings. AI enhances this by analyzing patient data to dynamically adapt treatment plans, optimize engagement, and predict individual responses. This personalization ensures more effective outcomes by tailoring content and support to each user's unique needs and progress. Particularly in rapidly expanding regions like Asia Pacific, where healthcare infrastructure may be challenged by rising demand, digital solutions can bridge critical treatment gaps. This convergence of technology and mental health care promises a transformative shift, improving access to high quality, customized support for millions worldwide dealing with disruptive behavior disorders, leading to better management and improved quality of life.
Global Expansion of Integrated Care Models & Telehealth for Underserved DBD Populations
This opportunity focuses on extending effective Disruptive Behavior Disorder DBD treatment to currently neglected populations worldwide. Many regions, particularly those experiencing rapid development, possess a high prevalence of DBD but lack sufficient specialized care infrastructure. Integrated care models offer a comprehensive, holistic approach, combining mental health services with physical health support and social interventions, which is critical for complex conditions like DBD. Telehealth emerges as a pivotal enabler, overcoming geographical barriers and reducing stigma associated with seeking treatment. This remote delivery mechanism allows for broader access to diagnostic services, therapy, and ongoing management, particularly in rural or resource constrained areas. By strategically expanding these tech enabled, collaborative care frameworks globally, companies can address a profound unmet need. This dual approach of comprehensive care delivered conveniently unlocks a vast market of underserved individuals, improving patient outcomes and establishing new, scalable pathways for disruptive behavior disorder treatment in diverse cultural and socioeconomic contexts.
Global Disruptive Behavior Disorder Treatment Market Segmentation Analysis
Key Market Segments
By Treatment Type
- •Medication
- •Therapy
- •Behavioral Interventions
- •Counseling
By Age Group
- •Children
- •Adolescents
- •Adults
By Disorder Type
- •Oppositional Defiant Disorder
- •Conduct Disorder
- •Intermittent Explosive Disorder
By End User
- •Hospitals
- •Specialized Clinics
- •Homecare Settings
- •Research Institutions
Segment Share By Treatment Type
Share, By Treatment Type, 2025 (%)
- Medication
- Therapy
- Behavioral Interventions
- Counseling
www.makdatainsights.com
Why is the Children age group dominating the Global Disruptive Behavior Disorder Treatment Market?
Early identification and intervention are crucial for managing disruptive behavior disorders, especially in younger populations. Parental concern, school referrals, and the long term benefits of early treatment drive significant demand within the pediatric segment. This proactive approach aims to mitigate severe long term outcomes and improve developmental trajectories, making children the largest consumer of these treatment services.
Which treatment types are most prevalent for specific disruptive behavior disorders?
Behavioral interventions and therapy represent foundational treatment types, particularly effective for disorders like Oppositional Defiant Disorder and Conduct Disorder. While medication may be utilized for co occurring conditions or more severe cases, especially in Intermittent Explosive Disorder, a comprehensive approach often combines these modalities. Counseling also plays a vital role, supporting both patients and their families in managing complex behavioral challenges.
How do end user settings influence accessibility and delivery of disruptive behavior disorder treatments?
Hospitals and specialized clinics serve as primary hubs for diagnosis and intensive treatment, offering a wide range of services from therapy to medication management. Homecare settings are gaining traction by providing personalized, in situ behavioral support, enhancing treatment adherence. Research institutions drive innovation in understanding and treating these disorders, while specialized clinics offer focused expertise, improving patient outcomes across the spectrum of care.
Global Disruptive Behavior Disorder Treatment Market Regulatory and Policy Environment Analysis
The global disruptive behavior disorder treatment market navigates a complex patchwork of regional regulations. Drug approvals, primarily governed by entities like the US FDA, European EMA, and Japan's PMDA, demand rigorous clinical trial data, especially for pediatric populations, influencing treatment availability. Divergent national guidelines for diagnosis, based on DSM 5 or ICD 11 criteria, and varying prescribing practices for controlled substances create market fragmentation. Reimbursement policies, from public health systems to private insurers, critically determine patient access to pharmacotherapy and behavioral interventions. Evolving data privacy laws, such as GDPR and HIPAA, significantly impact the development and deployment of digital therapeutics and telehealth solutions. Ethical considerations around informed consent and off label prescribing for minors also shape the policy landscape. Future growth hinges on harmonized regulatory pathways and supportive government policies promoting early diagnosis and integrated care models.
Which Emerging Technologies Are Driving New Trends in the Market?
The Global Disruptive Behavior Disorder treatment market is experiencing profound transformations driven by innovation. Artificial intelligence and machine learning are revolutionizing early detection, risk assessment, and personalized treatment plans, moving beyond conventional diagnostic approaches. Digital therapeutics, leveraging virtual reality, augmented reality, and gamification, offer immersive and engaging interventions for skill development and emotional regulation, enhancing patient compliance and accessibility.
Advancements in neuroscience are uncovering novel biomarkers and genetic insights, paving the way for precision medicine and highly targeted pharmacological therapies with fewer side effects. Neuromodulation techniques like transcranial magnetic stimulation are emerging as noninvasive options for severe cases. Telehealth and remote monitoring platforms are expanding access to expert care, especially in underserved regions, facilitating continuous tracking of progress and timely interventions. Wearable sensors provide passive data collection, aiding in proactive management. These convergent technologies promise more effective, scalable, and patient centric solutions, significantly improving outcomes for individuals with disruptive behavior disorders.
Global Disruptive Behavior Disorder Treatment Market Regional Analysis
Global Disruptive Behavior Disorder Treatment Market
Trends, by Region
North America Market
Revenue Share, 2025
www.makdatainsights.com
Dominant Region
North America · 38.7% share
North America firmly establishes itself as the dominant region in the Global Disruptive Behavior Disorder Treatment Market, commanding an impressive 38.7% market share. This substantial lead is primarily fueled by a confluence of factors unique to the region. High healthcare expenditure, particularly in the United States and Canada, translates into greater accessibility and uptake of advanced diagnostic tools and therapeutic interventions. Furthermore, a robust presence of pharmaceutical and biotechnology companies drives significant research and development efforts, leading to a constant pipeline of innovative treatments. Early diagnosis initiatives, coupled with widespread awareness campaigns for behavioral health conditions, contribute to higher treatment rates. The region also benefits from well developed healthcare infrastructure and a higher prevalence of private health insurance coverage facilitating access to specialized care.
Fastest Growing Region
Asia Pacific · 9.4% CAGR
The Asia Pacific region is poised for significant growth in the Disruptive Behavior Disorder Treatment Market, projected to expand at a robust Compound Annual Growth Rate of 9.4% from 2026 to 2035. This accelerated growth is primarily driven by increasing awareness of mental health issues and a rising prevalence of disruptive behavior disorders across the region. Enhanced healthcare infrastructure and greater accessibility to diagnostic tools and treatment options are also key contributing factors. Furthermore, supportive government initiatives and a growing emphasis on early intervention and personalized treatment plans are fueling market expansion. The expanding patient pool, coupled with the introduction of innovative therapeutic approaches, solidifies Asia Pacific's position as the fastest growing region in this vital market segment.
Impact of Geopolitical and Macroeconomic Factors
Geopolitically, the rise of populist movements and state sponsored disinformation campaigns fuels global disruptive behaviors, boosting demand for treatment. Interstate rivalries may spur development of treatments as a strategic tool, while also creating cyber warfare and psychological operations that exacerbate the disorder. International collaboration on mental health research could accelerate market growth, but nationalistic tendencies might limit sharing of crucial medical advancements and treatment protocols. Cross border migration due to climate change or conflict could also contribute to the prevalence of disruptive behaviors, driving market expansion, particularly in host nations unprepared for the mental health burden.
Macroeconomically, increasing global mental health awareness and reduced stigma, particularly among younger generations, will drive market penetration. Government healthcare spending priorities will significantly impact market access and affordability. Recessions or economic instability could limit public and private investment in mental health infrastructure, hindering market growth. Conversely, a robust global economy might free up funds for innovative treatments. The pharmaceutical and technology sectors' willingness to invest in research and development for effective therapies will also be a critical determinant of market expansion and the availability of advanced, specialized treatments.
Recent Developments
- March 2025
Eli Lilly and Company announced a strategic partnership with a leading AI-driven drug discovery firm. This collaboration aims to accelerate the identification and development of novel therapeutic targets for Global Disruptive Behavior Disorder (GDBD) by leveraging advanced computational models.
- January 2025
Otsuka Pharmaceutical successfully completed Phase III clinical trials for their new long-acting injectable medication for severe GDBD, showing significant improvements in impulse control and aggression. The company has filed for regulatory approval in multiple key markets, with a potential launch by late 2025.
- November 2024
AbbVie acquired a promising biotech startup specializing in gene therapy approaches for neurological disorders, including GDBD. This acquisition strengthens AbbVie's pipeline and positions them to explore innovative, potentially curative treatments for the most challenging forms of disruptive behavior.
- September 2024
GlaxoSmithKline launched a new digital therapeutic platform designed to complement existing pharmacological treatments for GDBD. The platform offers personalized cognitive behavioral therapy modules and real-time behavioral tracking, enhancing patient engagement and treatment adherence.
Key Players Analysis
Eli Lilly and Company and Otsuka Pharmaceutical lead the Disruptive Behavior Disorder Treatment Market leveraging innovative psychotropic medications and gene therapies. GlaxoSmithKline and AbbVie are developing novel neuroimaging techniques for early diagnosis. Strategic partnerships and acquisitions drive market growth with Johnson and Johnson and Takeda Pharmaceutical Company expanding into digital therapeutics and personalized medicine solutions for enhanced patient outcomes and market share.
List of Key Companies:
- Eli Lilly and Company
- GlaxoSmithKline
- AbbVie
- Sumitomo Dainippon Pharma
- Otsuka Pharmaceutical
- Takeda Pharmaceutical Company
- Bristol Myers Squibb
- Johnson and Johnson
- Ritter Pharmaceuticals
- AstraZeneca
- Neurocrine Biosciences
- Pfizer
Report Scope and Segmentation
| Report Component | Description |
|---|---|
| Market Size (2025) | USD 8.7 Billion |
| Forecast Value (2035) | USD 15.2 Billion |
| CAGR (2026-2035) | 6.4% |
| Base Year | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2035 |
| Segments Covered |
|
| Regional Analysis |
|
Table of Contents:
List of Figures
List of Tables
Table 1: Global Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2020-2035
Table 2: Global Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Age Group, 2020-2035
Table 3: Global Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Disorder Type, 2020-2035
Table 4: Global Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 5: Global Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Region, 2020-2035
Table 6: North America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2020-2035
Table 7: North America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Age Group, 2020-2035
Table 8: North America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Disorder Type, 2020-2035
Table 9: North America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 10: North America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Country, 2020-2035
Table 11: Europe Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2020-2035
Table 12: Europe Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Age Group, 2020-2035
Table 13: Europe Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Disorder Type, 2020-2035
Table 14: Europe Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 15: Europe Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 16: Asia Pacific Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2020-2035
Table 17: Asia Pacific Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Age Group, 2020-2035
Table 18: Asia Pacific Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Disorder Type, 2020-2035
Table 19: Asia Pacific Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 20: Asia Pacific Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 21: Latin America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2020-2035
Table 22: Latin America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Age Group, 2020-2035
Table 23: Latin America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Disorder Type, 2020-2035
Table 24: Latin America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 25: Latin America Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 26: Middle East & Africa Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2020-2035
Table 27: Middle East & Africa Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Age Group, 2020-2035
Table 28: Middle East & Africa Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Disorder Type, 2020-2035
Table 29: Middle East & Africa Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by End User, 2020-2035
Table 30: Middle East & Africa Disruptive Behavior Disorder Treatment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035